Integrichain Blog

Blog

Three Pharma regulatory consultants working at a table and planning their pharma gross-to-net strategy

Contracts & Pricing Jeff Baab Jason Zemcik
April 11, 2022

Best Price and Copay Challenges: Frequently Asked Questions

11 Minute Read

Common manufacturer concerns on best price calculations, copay accumulators and maximizers, and 340B management as the effective date for the CMS Final Rule approaches.

Contracts & Pricing Brian Bumpus Matt Cunningham
March 28, 2022

Medicare Part B Sequestration Update

3 Minute Read

Regulatory Market Update Updates for Pharma Manufacturers As always, if you have questions on any of the content found in this or previous market updates, please reach out to...

Contracts & Pricing Olivia Nweze Gourab Khan Ben Fanelli
February 24, 2022

Branded Pharma Fee: Manufacturer Considerations

5 Minute Read

And other regulatory updates on Line Extension guidance, the upcoming DUNS number transition, and emergency 340B flexibilities.

Contracts & Pricing Gourab Khan
January 24, 2022

New Year, New Laws: Drug Price Reform, Coverage Gap, and 340B

4 Minute Read

Potential and pending regulatory changes in 2022 including the current status of the Build Back Better Act and Part D Benefit Design.

Channel Olivia Nweze Tim Keys
December 20, 2021

Retail Pharmacy’s Digital Transformation

3 Minute Read

As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?

Contracts & Pricing Brendan Crabtree
November 23, 2021

Regulatory Updates

4 Minute Read

This month we discuss COVID-19 vaccine mandates, the recent HHS drug discount ruling, and Medicare drug price reforms.

Contracts & Pricing Ben Fanelli Kevin Ehmann
October 20, 2021

The New Plan for Addressing High Drug Prices

4 Minute Read

We discuss the Biden administration's plan for combatting high drug prices, the new PBM public law reporting cycle, and MA and Part D rule for 2022.

Hospital hallway with medical icons overlaid, emphasizing the importance of Inflation Reduction Act guidance for pharmaceutical manufacturers

Contracts & Pricing Brendan Crabtree Kevin Ehmann
September 17, 2021

How Discount Cards Are Replacing PBMs

3 Minute Read

We review how discount cards have disrupted the prescription market as well as updates to the most-favored-nation pricing model and new STPR laws in Maine.

Contracts & Pricing Ben Fanelli
August 13, 2021

Compliance Guidelines for Government Programs

5 Minute Read

Six key elements to operate an effective compliance program. Also, new VA FSS rules for vaccine drugs, State Price Transparency, and Medicare Part D updates and reminders.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article